Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study
Multiple myeloma (MM) is a hematological malignancy of clonal antibody–secreting plasma cells (PCs). MM diagnosis and risk stratification rely on bone marrow (BM) biopsy, an invasive procedure prone to sample bias. Liquid biopsies, such as extracellular vesicles (EV) in peripheral blood (PB), hold p...
Main Authors: | Bruna Velosa Ferreira, Emilie Arnault Carneiro, Carolina Pestana, Filipa Barahona, Joana Caetano, Raquel Lopes, Paulo Lúcio, Manuel Neves, Hans Christian Beck, Ana Sofia Carvalho, Rune Matthiesen, Bruno Costa-Silva, Cristina João |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.860849/full |
Similar Items
-
Boosting Immunity against Multiple Myeloma
by: Raquel Lopes, et al.
Published: (2021-03-01) -
Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
by: Raquel Lopes, et al.
Published: (2022-07-01) -
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
by: Raquel Lopes, et al.
Published: (2021-02-01) -
Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
by: Joana Caetano, et al.
Published: (2022-06-01) -
P821: HIGH-DIMENSIONAL SPECTRAL CYTOMETRY CHARACTERIZATION OF THE CIRCULATING IMMUNE CELL PROFILE IN ASYMPTOMATIC AND SYMPTOMATIC MYELOMA PATIENTS.
by: Joana Caetano, et al.
Published: (2023-08-01)